Tranexamic Acid for Melasma and Dark Spots: How It Works and Who It Suits

If you have been dealing with melasma, post-inflammatory hyperpigmentation (PIH), or stubborn dark spots that have not responded to Vitamin C alone, Tranexamic Acid (TXA) may be the active ingredient your routine has been missing. In this guide, we explain the science behind TXA, why it works particularly well for Indian skin, and how to use it correctly for measurable results.

Table of Contents

  1. What Is Tranexamic Acid?
  2. How TXA Works on Pigmentation
  3. Melasma vs PIH vs Sun Spots: Which Does TXA Target?
  4. TXA and Indian Skin: Why It Matters
  5. The Clinical Evidence for TXA
  6. TXA vs Vitamin C vs Kojic Acid: How They Compare
  7. How to Use TXA Serum in Your Routine
  8. What Results to Expect and When
  9. Who Should Not Use TXA?
  10. Frequently Asked Questions

1. What Is Tranexamic Acid?

Tranexamic Acid (TXA) is a synthetic derivative of the amino acid lysine. It was originally developed as a haemostatic agent — used medically to prevent excessive bleeding by inhibiting fibrinolysis. Its application in dermatology is more recent, beginning with the observation that patients taking oral TXA for other conditions showed unexpected improvement in melasma.

Topical TXA is now one of the most evidence-backed brightening actives available in skincare. Unlike older brightening agents, it works through a distinct mechanism that targets the root cause of UV-induced pigmentation, rather than simply blocking melanin production at a single step.

In Ayurvedic correspondence, TXA's action aligns with the Varnya Gana framework — the classical category of herbs and actives that restore Varna (complexion) by addressing the root causes of discolouration in Rakta dhatu (blood tissue) and Bhrajaka Pitta (the sub-dosha governing skin lustre).


2. How TXA Works on Pigmentation

When skin is exposed to UV radiation, keratinocytes release a signalling molecule called plasminogen, which activates plasmin. Plasmin then stimulates melanocytes to produce more melanin — causing the darkening associated with sun exposure, melasma, and PIH.

TXA interrupts this pathway: it is a competitive inhibitor of plasminogen. By blocking plasmin activation, TXA prevents the upstream signal that triggers excess melanin production. This mechanism makes TXA fundamentally different from Vitamin C (which inhibits tyrosinase) — they target different points in the same pathway and work synergistically together.


3. Melasma vs PIH vs Sun Spots: Which Does TXA Target?

Melasma

Melasma is a chronic hyperpigmentation condition driven by UV exposure, hormonal triggers, and genetic predisposition. Indian women have a significantly higher incidence of melasma than European populations. TXA is particularly effective for melasma because melasma pigmentation is heavily driven by the UV-plasmin-melanocyte pathway that TXA targets.

Post-Inflammatory Hyperpigmentation (PIH)

PIH is the dark mark left after skin inflammation — acne, insect bites, or any wound. Darker skin tones (Fitzpatrick IV-VI, which includes most Indian skin) are significantly more prone to PIH. TXA helps PIH by reducing the inflammatory signalling that drives post-injury melanin production.

Sun Spots (Solar Lentigines)

Sun spots are discrete, flat areas of pigmentation from cumulative UV exposure. TXA is moderately effective for sun spots, though the mechanism is less direct than for melasma.


4. TXA and Indian Skin: Why It Matters

  • Higher melanocyte activity — more pigment produced in response to UV, inflammation, and hormonal triggers
  • Greater PIH tendency — any skin insult is more likely to leave a lasting dark mark
  • Higher melasma prevalence — Indian women have among the highest global rates of melasma
  • Year-round UV exposure — India's climate continuously triggers the plasmin-melanocyte pathway TXA targets

Hydroquinone carries significant risks and is not available OTC in India. TXA represents one of the most effective non-prescription alternatives, with a safety profile appropriate for long-term use.


5. The Clinical Evidence for TXA

  • A 2020 RCT comparing topical TXA to hydroquinone found TXA produced comparable brightening with significantly fewer side effects
  • Multiple studies confirm 2-5% topical TXA reduces melanin index in 8-12 weeks
  • A 2022 review confirmed TXA's dual mechanism — plasminogen inhibition and direct tyrosinase inhibition
  • Combination studies show TXA + Niacinamide produces superior results to either active alone

6. TXA vs Vitamin C vs Kojic Acid

Active Mechanism Best for Stability Irritation risk
TXA Plasminogen inhibition + tyrosinase inhibition Melasma, PIH, UV pigmentation High Low
Vitamin C Tyrosinase inhibition + antioxidant General brightening, dullness Low Medium
Kojic Acid Copper chelation (tyrosinase) Sun spots, brightening Medium Medium-High
Alpha Arbutin Tyrosinase + melanosome inhibition PIH, sensitive skin High Low

7. How to Use TXA Serum in Your Routine

Morning

  1. Cleanse — MoringAloe Face Cleanser
  2. Tone — Gulab Ark Rose Water
  3. Vitamin C Serum — 15% Vitamin C Brightening Serum
  4. Moisturise — Ultra-Lightweight Glow Gel
  5. SPF 50+

Evening

  1. Cleanse — MoringAloe Face Cleanser
  2. Tone — Gulab Ark Rose Water
  3. TXA Serum — TXA Peptides Face Serum — 3-4 drops, press gently
  4. Face Oil — Kumkumadi Face Oil

8. What Results to Expect and When

Timeline What to Expect
Week 1-2 No visible change yet — TXA working at cellular level. Continue consistently.
Week 3-4 Subtle brightening begins. Dark spots may appear slightly lighter.
Week 6-8 Visible reduction in dark spots and PIH. Melasma patches begin to fade.
Week 10-12 Significant improvement in overall skin tone. Most PIH resolved.

9. Who Should Not Use TXA?

  • Pregnant or breastfeeding — consult a dermatologist
  • Active rosacea or broken skin barrier
  • Known sensitivity to TXA — patch test essential
  • Children under 12

Frequently Asked Questions

How is TXA different from Vitamin C?
Vitamin C inhibits tyrosinase. TXA works earlier — blocking the UV-triggered plasminogen signal that tells melanocytes to produce more pigment. They target different steps and work synergistically together.

Can I use TXA serum every day?
Yes. TXA is stable, non-irritating, suitable for daily use. Clinical studies use daily application over 8-12 weeks.

Does TXA work for hormonal melasma?
Yes — TXA is one of the most effective topical options for hormonal melasma. With consistent use and strict SPF, it produces significant improvement.

Can I use TXA with Niacinamide?
Yes — synergistic combination. Velleja's TXA Peptides Serum combines both actives in one formula.


The Velleja TXA Peptides Serum

Velleja's TXA Peptides Face Serum combines Tranexamic Acid with Niacinamide and Peptides — targeting pigmentation, skin tone, and collagen support simultaneously within a pure, authentic Ayurvedic botanical base.

Explore Velleja's Pigmentation Range →


Medical disclaimer: This article is for informational purposes only and does not constitute medical advice.


A

About the Author

Dr. Anoop Singh

Dr. Anoop Singh is Founding Partner & Formulation Scientist at Velleja. With a PhD in Pharmaceutical Sciences, MBA from IIM Trichy, and 13+ years in skincare and Ayurvedic product formulation, he leads all product innovation and ingredient science at Velleja — combining pure, authentic Ayurveda with proven & validated modern actives.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.